{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:20:31Z","timestamp":1776309631578,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ejmech.2014.07.055","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T17:15:17Z","timestamp":1405617317000},"page":"537-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: Cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase"],"prefix":"10.1016","volume":"84","author":[{"given":"Gabrieli L.","family":"Parrilha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina S.O.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josane A.","family":"Lessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kely Navakoski","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo L.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas P.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine M.","family":"Souza-Fagundes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8593-4555","authenticated-orcid":false,"given":"Heloisa","family":"Beraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.07.055_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2014.07.055_bib2","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","article-title":"A\u00a0history of cancer chemotherapy","volume":"68","author":"DeVita","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2014.07.055_bib3","series-title":"Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug","year":"1999"},{"key":"10.1016\/j.ejmech.2014.07.055_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ica.2012.06.003","article-title":"Gallium complexes as new promising metallodrug candidates","volume":"393","author":"Lessa","year":"2012","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ejmech.2014.07.055_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/med.20168","article-title":"Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies","volume":"30","author":"Nobili","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2014.07.055_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1040-8428(01)00217-7","article-title":"Antimony and bismuth compounds in oncology","volume":"42","author":"Tiekink","year":"2002","journal-title":"Crit. Rev. Onc. Hemat."},{"key":"10.1016\/j.ejmech.2014.07.055_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2533\/chimia.2007.692","article-title":"Ruthenium anticancer compounds: challenges and expectations","volume":"61","author":"Bratsos","year":"2007","journal-title":"Chimia"},{"key":"10.1016\/j.ejmech.2014.07.055_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1039\/C0MD00181C","article-title":"Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays","volume":"2","author":"Gabbiani","year":"2011","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2014.07.055_bib9","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1046\/j.1432-1327.2000.01703.x","article-title":"Thioredoxin reductase as a pathophysiological factor and drug target","volume":"267","author":"Becker","year":"2000","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.ejmech.2014.07.055_bib10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.ccr.2009.02.019","article-title":"On the medicinal chemistry of gold complexes as anticancer drugs","volume":"253","author":"Ott","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2014.07.055_bib11","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.ccr.2009.02.026","article-title":"Thioredoxin reductase: a target for gold compounds acting as potential anticancer drugs","volume":"253","author":"Bindoli","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2014.07.055_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.freeradbiomed.2011.10.447","article-title":"Small molecule inhibitors of mammalian thioredoxin reductase","volume":"52","author":"Cai","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2014.07.055_bib13","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1021\/jm0708578","article-title":"Activity of rat cytosolic thioredoxin reductase is strongly decreased by trans-[bis(2-amino-5-methylthiazole)tetrachlororuthenate(III)]: first report of relevant thioredoxin reductase inhibition for a ruthenium compound","volume":"50","author":"Mura","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib14","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1039\/C2DT32319B","article-title":"Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules","volume":"42","author":"Oehninger","year":"2013","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.ejmech.2014.07.055_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cmdc.201200505","article-title":"Butyltin(IV) benzoates: inhibition of thioredoxin reductase, tumor cell growth inhibition, and interactions with proteins","volume":"8","author":"de Oliveira","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2014.07.055_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1389557043487484","article-title":"The wide pharmacological versatility of semicarbazones, thiosemicarbazones and their metal complexes","volume":"4","author":"Beraldo","year":"2004","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib17","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jinorgbio.2011.07.003","article-title":"Ribonucleotide reductase inhibition by metal complexes of triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study","volume":"105","author":"Popovi\u0107-Bijeli\u0107","year":"2011","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10534-012-9603-1","article-title":"Gallium(III) complexes with 2-acetylpyridine-derived thiosemicarbazones: antimicrobial and cytotoxic effects and investigation on the interactions with tubulin","volume":"26","author":"Lessa","year":"2013","journal-title":"Biometals"},{"key":"10.1016\/j.ejmech.2014.07.055_bib19","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.ejmech.2008.11.006","article-title":"Gallium(III) complexes of 2-pyridineformamide thiosemicarbazones: cytotoxic activity against malignant glioblastoma","volume":"44","author":"Mendes","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.poly.2010.10.014","article-title":"N(4)-tolyl-2-benzoylpyridine-derived thiosemicarbazones and their palladium(II) and platinum(II) complexes: cytotoxicity against human solid tumor cells","volume":"30","author":"Ferraz","year":"2011","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2014.07.055_bib21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jinorgbio.2011.09.008","article-title":"Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity","volume":"105","author":"Lessa","year":"2011","journal-title":"J.\u00a0Inorg. Biochem"},{"key":"10.1016\/j.ejmech.2014.07.055_bib22","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1016\/j.ejmech.2010.05.044","article-title":"Antimony(III) complexes with 2-benzoylpyridine-derived thiosemicarbazones: cytotoxicity against human leukemia cell lines","volume":"45","author":"Reis","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejmech.2005.01.006","article-title":"Structural studies and cytotoxic activity of N(4)-phenyl-2-benzoylpyridine thiosemicarbazone Sn(IV) complexes","volume":"40","author":"Perez-Rebolledo","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib24","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1016\/j.bmc.2009.08.063","article-title":"2-Benzoylpyridine-N(4)-tolyl thiosemicarbazones and their palladium(II) complexes: cytotoxicity against leukemia cells","volume":"17","author":"Ferraz","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib25","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1016\/j.ejmech.2010.09.021","article-title":"2-Acetylpyridine thiosemicarbazones: cytotoxic activity in nanomolar doses against malignant gliomas","volume":"45","author":"Lessa","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib26","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.bmc.2012.04.027","article-title":"N4-Phenyl-substituted 2-acetylpyridine thiosemicarbazones: cytotoxicity against human tumor cells, structure\u2013activity relationship studies and investigation on the mechanism of action","volume":"20","author":"Soares","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib27","first-page":"4131","article-title":"The cytotoxicity of copper(II) complexes of 2-acetyl-pyridil-4-N-substituted thiosemicarbazones","volume":"18","author":"Miller","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2014.07.055_bib28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.poly.2011.10.018","article-title":"2-Acetylpyridine- and 2-benzoylpyridine-derived thiosemicarbazones and their antimony(III) complexes exhibit high anti-trypanosomal activity","volume":"31","author":"Parrilha","year":"2012","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2014.07.055_bib29","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.ejmech.2011.01.041","article-title":"Pyridine-derived thiosemicarbazones and their tin(IV) complexes with antifungal activity against Candida spp.","volume":"46","author":"Parrilha","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib30","unstructured":"CRYSALISPRO, Agilent Technologies, Version 1.171.35.21 (release 20-01-2012 CrysAlis171.NET)."},{"key":"10.1016\/j.ejmech.2014.07.055_bib31","unstructured":"SCALE3 ABSPACK Scaling Algorithm CrysAlis, Agilent Technologies, Version 1.171.35.21 (release 20-01-2012 CrysAlis171NET)."},{"key":"10.1016\/j.ejmech.2014.07.055_bib32","series-title":"SHELXS-97, Program for the Solution of Crystal Structures","author":"Sheldrick","year":"1997"},{"key":"10.1016\/j.ejmech.2014.07.055_bib33","series-title":"SHELXL-97, Program for the Refinement of Crystal Structures","author":"Sheldrick","year":"1997"},{"key":"10.1016\/j.ejmech.2014.07.055_bib34","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1021\/jm100801e","article-title":"Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties","volume":"53","author":"Rubbiani","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib35","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jnci\/83.11.757","article-title":"Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines","volume":"83","author":"Monks","year":"1991","journal-title":"J.\u00a0Nat. Cancer Inst."},{"key":"10.1016\/j.ejmech.2014.07.055_bib36","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.inoche.2004.09.021","article-title":"Formation of first gold(III) complex of an N(4)-disubstituted thiosemicarbazone derived from 2-benzoylpyridine: structural and spectral studies","volume":"7","author":"Sreeknth","year":"2004","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.ejmech.2014.07.055_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0162-0134(96)00142-0","volume":"65","author":"Borges","year":"1997","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1013441400773","article-title":"Cobalt(II) and nickel(II) complexes of N(4') substituted 3- and 4-acetylpyridine thiosemicarbazones","volume":"27","author":"Beraldo","year":"2002","journal-title":"Transit. Metal. Chem."},{"key":"10.1016\/j.ejmech.2014.07.055_bib39","series-title":"Infrared Spectra of Inorganic and Coordination Compounds","author":"Nakamoto","year":"1986"},{"key":"10.1016\/j.ejmech.2014.07.055_bib40","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.poly.2009.04.022","article-title":"Increasing the antibacterial activity of gallium(III) against Pseudomonas aeruginosa upon coordination to pyridine-derived thiosemicarbazones","volume":"28","author":"Da Silva","year":"2009","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2014.07.055_bib41","first-page":"235","article-title":"Antiproliferative and anti-tumor activity of organotin compounds Coord","volume":"253","author":"Hadjikakou","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2014.07.055_bib42","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.freeradbiomed.2005.04.025","article-title":"Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds","volume":"39","author":"Witte","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2014.07.055_bib43","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1039\/c3md00076a","article-title":"TrxR inhibition and antiproliferative activities of structurally diverse gold N-heterocyclic carbene complexes","volume":"4","author":"Rubbiani","year":"2013","journal-title":"MedChemComm"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341400662X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341400662X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T10:35:55Z","timestamp":1598092555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341400662X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":43,"alternative-id":["S022352341400662X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.055","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: Cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}